Comparative study of analgesic effect of intrathecal nalbuphine and fentanyl as an adjuvant to 0.75% Ropivacaine in infra umbilical surgeries

A Comparative Study of Analgesic Effect of Intrathecal Nalbuphine and Fentanyl as an Adjuvant to 0.75% Ropivacaine in Infra-Umbilical Surgeries - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/079972

Enrollment

Registered

2025-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Fentanyl : Fentanyl dose- 25 mcg Route- intrathecal 25 mcg fentanyl+ 3 ml 0.75 % Ropivacaine Intervention2: Nalbuphine: Dose of nalbuphine -1mg Route- intrathecal 1mg Nalbuphine Wit

Eligibility

Inclusion criteria

Inclusion criteria: 1-Elective infra umbilical surgeries 2-BMI-18.5-29.9kg/m2 3-ASA physical status1&2

Exclusion criteria

Exclusion criteria: 1-Patient having contraindications to spinal anaesthesia 2-Pregnancy 3-Patient allergic to local anaesthesia 4-Peripheral vascular disease 5- Patient with known or suspected autonomic neuropathy

Design outcomes

Primary

Measure	Time frame
Compare the analgesic effect of nalbuphine and fentanyl as an adjuvant to 0.75% ropivacaineTimepoint: Instant after intrathecal adminstration, then 30 min after adminstration then continue for 6 hr. at a interval of 30 min.	—

Secondary

Measure	Time frame
Less need of repetition of other analgesic with nalbuphine if use as an adjuvant to 0.75% Ropivacaine intrathecallyTimepoint: After 30 min. Of intrathecal adminstration continue for 6 hr. at an interval of 30 min.	—

Countries

India, United Kingdom

Contacts

Public ContactArchana Kumari

AIIMS Deoghar

drsanjayaiims2012@gmail.com7063956225

Outcome results